Current Treatment for Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree. A selective literature search with additional scrutiny of guidelines and meta-analyses. The management of patients...

Full description

Saved in:
Bibliographic Details
Published in:Deutsches Ärzteblatt international 2020-12, Vol.117 (49), p.843-854
Main Authors: Miernik, Arkadiusz, Gratzke, Christian
Format: Article
Language:English
Subjects:
Continuing Medical Education
Humans
Laser Therapy
Male
Middle Aged
Prostatectomy
Prostatic Hyperplasia - diagnosis
Prostatic Hyperplasia - surgery
Transurethral Resection of Prostate
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c357t-2a82da3604ac3a839799a8c6458380f661c8fa770a641ae39b5b2e04cd983d383
cites
container_end_page 854
container_issue 49
container_start_page 843
container_title Deutsches Ärzteblatt international
container_volume 117
creator Miernik, Arkadiusz
Gratzke, Christian
description Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree. A selective literature search with additional scrutiny of guidelines and meta-analyses. The management of patients with BPH is complex. Emptying and retention disorders can be treated by various pharmacological and surgical means. Transurethral resection of the prostate (TURP) has long been considered the gold standard for operative treatment. Transurethral enucleation procedures show a better risk profile in some uses, however, and have, above all, largely displaced suprapubic prostatectomy. Numerous innovative treatment options have been developed in recent years, but their long-term effects remain to be determined. These treatment techniques can nevertheless be used in individual cases after thorough discussion with the patient. The care of patients with BPH should be interdisciplinary. The efficacy and safety of many new developments in the area of pharmacological and minimally invasive treatment remain to be demonstrated in randomized trials.
doi_str_mv 10.3238/arztebl.2020.0843
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8021971</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2490608072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-2a82da3604ac3a839799a8c6458380f661c8fa770a641ae39b5b2e04cd983d383</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdBbK3-AC-So5fUyc5mPy6CFrVCQQ_1HCabTY3ky91EqL_eilX0NC_My_MMw9hZAnPkqC_Jfwwur-ccOMxBCzxg00RLGYNI-YQdh_AKIBPD8YhNEFODQpkp44vRe9cO0do7GpqvVHY-unFttWmjJ9-FgYbKRstt73xfU6johB2WVAd3up8z9nx3u14s49Xj_cPiehVbTNUQc9K8IJQgyCJpNMoY0laKVKOGUsrE6pKUApIiIYcmT3PuQNjCaCxQ44xdfXP7MW9cYXe3eaqz3lcN-W3WUZX937TVS7bp3jMNPDEq2QEu9gDfvY0uDFlTBevqmlrXjSHjwoAEDYrvqud_Xb-Sn0fhJxInajw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2490608072</pqid></control><display><type>article</type><title>Current Treatment for Benign Prostatic Hyperplasia</title><source>PubMed Central</source><creator>Miernik, Arkadiusz ; Gratzke, Christian</creator><creatorcontrib>Miernik, Arkadiusz ; Gratzke, Christian</creatorcontrib><description>Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree. A selective literature search with additional scrutiny of guidelines and meta-analyses. The management of patients with BPH is complex. Emptying and retention disorders can be treated by various pharmacological and surgical means. Transurethral resection of the prostate (TURP) has long been considered the gold standard for operative treatment. Transurethral enucleation procedures show a better risk profile in some uses, however, and have, above all, largely displaced suprapubic prostatectomy. Numerous innovative treatment options have been developed in recent years, but their long-term effects remain to be determined. These treatment techniques can nevertheless be used in individual cases after thorough discussion with the patient. The care of patients with BPH should be interdisciplinary. The efficacy and safety of many new developments in the area of pharmacological and minimally invasive treatment remain to be demonstrated in randomized trials.</description><identifier>EISSN: 1866-0452</identifier><identifier>DOI: 10.3238/arztebl.2020.0843</identifier><identifier>PMID: 33593479</identifier><language>eng</language><publisher>Germany: Deutscher Arzte Verlag</publisher><subject>Continuing Medical Education ; Humans ; Laser Therapy ; Male ; Middle Aged ; Prostatectomy ; Prostatic Hyperplasia - diagnosis ; Prostatic Hyperplasia - surgery ; Transurethral Resection of Prostate ; Treatment Outcome</subject><ispartof>Deutsches Ärzteblatt international, 2020-12, Vol.117 (49), p.843-854</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-2a82da3604ac3a839799a8c6458380f661c8fa770a641ae39b5b2e04cd983d383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021971/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021971/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33593479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miernik, Arkadiusz</creatorcontrib><creatorcontrib>Gratzke, Christian</creatorcontrib><title>Current Treatment for Benign Prostatic Hyperplasia</title><title>Deutsches Ärzteblatt international</title><addtitle>Dtsch Arztebl Int</addtitle><description>Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree. A selective literature search with additional scrutiny of guidelines and meta-analyses. The management of patients with BPH is complex. Emptying and retention disorders can be treated by various pharmacological and surgical means. Transurethral resection of the prostate (TURP) has long been considered the gold standard for operative treatment. Transurethral enucleation procedures show a better risk profile in some uses, however, and have, above all, largely displaced suprapubic prostatectomy. Numerous innovative treatment options have been developed in recent years, but their long-term effects remain to be determined. These treatment techniques can nevertheless be used in individual cases after thorough discussion with the patient. The care of patients with BPH should be interdisciplinary. The efficacy and safety of many new developments in the area of pharmacological and minimally invasive treatment remain to be demonstrated in randomized trials.</description><subject>Continuing Medical Education</subject><subject>Humans</subject><subject>Laser Therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prostatectomy</subject><subject>Prostatic Hyperplasia - diagnosis</subject><subject>Prostatic Hyperplasia - surgery</subject><subject>Transurethral Resection of Prostate</subject><subject>Treatment Outcome</subject><issn>1866-0452</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkE1Lw0AQhhdBbK3-AC-So5fUyc5mPy6CFrVCQQ_1HCabTY3ky91EqL_eilX0NC_My_MMw9hZAnPkqC_Jfwwur-ccOMxBCzxg00RLGYNI-YQdh_AKIBPD8YhNEFODQpkp44vRe9cO0do7GpqvVHY-unFttWmjJ9-FgYbKRstt73xfU6johB2WVAd3up8z9nx3u14s49Xj_cPiehVbTNUQc9K8IJQgyCJpNMoY0laKVKOGUsrE6pKUApIiIYcmT3PuQNjCaCxQ44xdfXP7MW9cYXe3eaqz3lcN-W3WUZX937TVS7bp3jMNPDEq2QEu9gDfvY0uDFlTBevqmlrXjSHjwoAEDYrvqud_Xb-Sn0fhJxInajw</recordid><startdate>20201204</startdate><enddate>20201204</enddate><creator>Miernik, Arkadiusz</creator><creator>Gratzke, Christian</creator><general>Deutscher Arzte Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201204</creationdate><title>Current Treatment for Benign Prostatic Hyperplasia</title><author>Miernik, Arkadiusz ; Gratzke, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-2a82da3604ac3a839799a8c6458380f661c8fa770a641ae39b5b2e04cd983d383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Continuing Medical Education</topic><topic>Humans</topic><topic>Laser Therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prostatectomy</topic><topic>Prostatic Hyperplasia - diagnosis</topic><topic>Prostatic Hyperplasia - surgery</topic><topic>Transurethral Resection of Prostate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miernik, Arkadiusz</creatorcontrib><creatorcontrib>Gratzke, Christian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Deutsches Ärzteblatt international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miernik, Arkadiusz</au><au>Gratzke, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current Treatment for Benign Prostatic Hyperplasia</atitle><jtitle>Deutsches Ärzteblatt international</jtitle><addtitle>Dtsch Arztebl Int</addtitle><date>2020-12-04</date><risdate>2020</risdate><volume>117</volume><issue>49</issue><spage>843</spage><epage>854</epage><pages>843-854</pages><eissn>1866-0452</eissn><abstract>Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree. A selective literature search with additional scrutiny of guidelines and meta-analyses. The management of patients with BPH is complex. Emptying and retention disorders can be treated by various pharmacological and surgical means. Transurethral resection of the prostate (TURP) has long been considered the gold standard for operative treatment. Transurethral enucleation procedures show a better risk profile in some uses, however, and have, above all, largely displaced suprapubic prostatectomy. Numerous innovative treatment options have been developed in recent years, but their long-term effects remain to be determined. These treatment techniques can nevertheless be used in individual cases after thorough discussion with the patient. The care of patients with BPH should be interdisciplinary. The efficacy and safety of many new developments in the area of pharmacological and minimally invasive treatment remain to be demonstrated in randomized trials.</abstract><cop>Germany</cop><pub>Deutscher Arzte Verlag</pub><pmid>33593479</pmid><doi>10.3238/arztebl.2020.0843</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1866-0452
ispartof Deutsches Ärzteblatt international, 2020-12, Vol.117 (49), p.843-854
issn 1866-0452
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8021971
source PubMed Central
subjects Continuing Medical Education
Humans
Laser Therapy
Male
Middle Aged
Prostatectomy
Prostatic Hyperplasia - diagnosis
Prostatic Hyperplasia - surgery
Transurethral Resection of Prostate
Treatment Outcome
title Current Treatment for Benign Prostatic Hyperplasia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T11%3A51%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20Treatment%20for%20Benign%20Prostatic%20Hyperplasia&rft.jtitle=Deutsches%20%C3%84rzteblatt%20international&rft.au=Miernik,%20Arkadiusz&rft.date=2020-12-04&rft.volume=117&rft.issue=49&rft.spage=843&rft.epage=854&rft.pages=843-854&rft.eissn=1866-0452&rft_id=info:doi/10.3238/arztebl.2020.0843&rft_dat=%3Cproquest_pubme%3E2490608072%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357t-2a82da3604ac3a839799a8c6458380f661c8fa770a641ae39b5b2e04cd983d383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2490608072&rft_id=info:pmid/33593479&rfr_iscdi=true